Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis

Acta Pharmacologica Sinica

Volumn 26, Issue 10, 2005, Pages 1253-1258

  Huang, Bei ^a   Porter, Gavin ^b  

^a ANHUI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

14 3 3 Protein; Kinase inhibitors; PI3K Akt pathway; PRAS40

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROLINE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; PROTEIN PRAS40; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG WITHDRAWAL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LUNG CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 14-3-3 PROTEINS; BREAST NEOPLASMS; BUTADIENES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; LUNG NEOPLASMS; MORPHOLINES; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSFECTION;

EID: 26044474979     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00184.x     Document Type: Article

References (19)

1. Khuri FR, Herbst RS, Fossella FV. Emerging therapies in non-small-cell lung cancer. Ann Oncol 2001; 12: 739-44.
2. Mc Williams A, Lam S. New approaches to lung cancer prevention. Curr Oncol Rep 2002; 4: 489-94.
3. Goodman GE. Lung cancer 1: prevention of lung cancer. Thorax 2002; 57: 994-9.
4. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278: 1073-7.
5. Vivanco I, Sawyers CI. The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2002; 2: 489-501.
6. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-7.
7. Manning BD, Cantley LC. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/ Akt pathway to mammalian target of rapmycin (mTOR) signaling. Biochem Soc Trans 2003; 31: 573-8.
8. Kovacina KS, Park GY, Bea SK, Gruzzetta AW, Schaefer E, Birnbaum MJ. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 2003; 12: 10189-94.
9. Saito A, Narasimhan P Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after Stroke: relationships with nerve growth factor. J Neurosci 2004; 24: 1584-93.
10. Zhang L, Chen J, Fu H. Suppression of apoptosis signal-regulating kinase 1 induced cell death by 14-3-3 protein. Proc Natl Acad Sci USA 1999; 96: 8511-5.
11. Chen J, Fujii K, Zhang L, Roberts T, Fu H. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA 2001; 14: 7783-8.
12. Goldman EH, Chen J, Fu H. Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at Ser967 and 14-3-3 dissociation. J Biol Chem 2004; 279: 10442-9.
13. Chun KH, Kosmeder JW, Sun S, Pezzuto JM, Lotan R, Hong WK. Effect of deguelin on the phosphatidylinositol 3-Kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Nat Cancer Inst 2003; 4: 292-302.
14. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI3K-Kinase. Science 1997; 276: 1848-50.
15. Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, et al. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 1998; 18: 5699-711.
16. Toker A, Cantley L. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997; 387: 673-6.
17. Kobayashi M, Nagata S, Iwasaki T. Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1999; 96: 4874-9.
18. Luo J, Manning BD, Cantley LC. Targeting the PI3K-akt pathway in human cancer: Rationale and promise. Cancer Cell 2003; 4: 257-62.
19. Fu H, Subramanian HRS, Masters SC. 14-3-3 Proteins: structure, function, and regulation. Ann Rev Pharmacol Toxicol 2000; 40: 619-49.